Literature DB >> 30315709

Role and mechanism of ROS scavengers in alleviating NLRP3-mediated inflammation.

Takami Sho1, JianXiong Xu1.   

Abstract

Inflammation, as a common immune response to various infections or injuries, can cause many dangerous and complicated diseases. Inflammasome is a protein complex playing a vital role in an inflammation process, and the nucleotide-binding oligomerization domain (NOD)-like receptor containing pyrin domain 3 (NLRP3) inflammasome has been the most-widely studied one. Recent evidence suggests the reactive oxygen species (ROS)-NLRP3 signaling pathway to be a possible NLRP3 inflammasome regulation model. Numerous recent preclinical reports indicate that application of antioxidants could scavenge excessive ROS and attenuate inflammatory responses through suppressing NLRP3 inflammasome activation. This article, at first, briefly overviews how ROS may mediate the regulation of NLRP3 inflammasome activation. Then, preclinical researches of various ROS scavengers for treating NLRP3 inflammasome-associated diseases are focused on and critically analyzed. Finally, the potential of antioxidant treatment as a therapy for inflammation is to be discussed, and perspectives on future research directions will be shared.
© 2018 International Union of Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  NLRP3 inflammasome; ROS; antioxidant biotechnology; inflammation; signal transduction pathway

Mesh:

Substances:

Year:  2018        PMID: 30315709     DOI: 10.1002/bab.1700

Source DB:  PubMed          Journal:  Biotechnol Appl Biochem        ISSN: 0885-4513            Impact factor:   2.431


  26 in total

1.  RND3 attenuates oxidative stress and vascular remodeling in spontaneously hypertensive rat via inhibiting ROCK1 signaling.

Authors:  Nan Wu; Fen Zheng; Na Li; Ying Han; Xiao-Qing Xiong; Jue-Jin Wang; Qi Chen; Yue-Hua Li; Guo-Qing Zhu; Ye-Bo Zhou
Journal:  Redox Biol       Date:  2021-12-06       Impact factor: 11.799

2.  In-vitro inhibition of NLRP3 inflammasome by 3,6-dihydroxyflavone (3,6-DHF): a therapeutic strategy for the treatment of chronic inflammatory and autoimmune diseases.

Authors:  Farheen Mansoor; Almas Jabeen; Syeda Farah Shah; Shabana U Simjee; Samina Bano; Shaheen Faizi
Journal:  Mol Cell Biochem       Date:  2022-08-11       Impact factor: 3.842

3.  Prognostic value of plasma level of superoxide dismutase in HBV-related acute-on-chronic liver failure.

Authors:  Naijuan Yao; Yajuan He; Yuchao Wu; Fei Wang; Zhen Tian
Journal:  BMC Gastroenterol       Date:  2022-06-25       Impact factor: 2.847

Review 4.  Molecular and Supramolecular Structure of the Mitochondrial Oxidative Phosphorylation System: Implications for Pathology.

Authors:  Salvatore Nesci; Fabiana Trombetti; Alessandra Pagliarani; Vittoria Ventrella; Cristina Algieri; Gaia Tioli; Giorgio Lenaz
Journal:  Life (Basel)       Date:  2021-03-15

5.  Eucalyptol alleviates inflammation and pain responses in a mouse model of gout arthritis.

Authors:  Chengyu Yin; Boyu Liu; Ping Wang; Xiaojie Li; Yuanyuan Li; Xiaoli Zheng; Yan Tai; Chuan Wang; Boyi Liu
Journal:  Br J Pharmacol       Date:  2020-02-12       Impact factor: 8.739

Review 6.  Protective effects of curcumin on chemical and drug-induced cardiotoxicity: a review.

Authors:  Fatemeh Yarmohammadi; A Wallace Hayes; Gholamreza Karimi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-03-05       Impact factor: 3.000

Review 7.  Trimethylamine/Trimethylamine-N-Oxide as a Key Between Diet and Cardiovascular Diseases.

Authors:  Siyu He; Hong Jiang; Caili Zhuo; Wei Jiang
Journal:  Cardiovasc Toxicol       Date:  2021-05-18       Impact factor: 3.231

8.  FNDC5 Attenuates Oxidative Stress and NLRP3 Inflammasome Activation in Vascular Smooth Muscle Cells via Activating the AMPK-SIRT1 Signal Pathway.

Authors:  Bing Zhou; Yun Qiu; Nan Wu; Ai-Dong Chen; Hong Zhou; Qi Chen; Yu-Ming Kang; Yue-Hua Li; Guo-Qing Zhu
Journal:  Oxid Med Cell Longev       Date:  2020-05-16       Impact factor: 6.543

Review 9.  Gut Microbiota-Dependent Marker TMAO in Promoting Cardiovascular Disease: Inflammation Mechanism, Clinical Prognostic, and Potential as a Therapeutic Target.

Authors:  Shengjie Yang; Xinye Li; Fan Yang; Ran Zhao; Xiandu Pan; Jiaqi Liang; Li Tian; Xiaoya Li; Longtao Liu; Yanwei Xing; Min Wu
Journal:  Front Pharmacol       Date:  2019-11-19       Impact factor: 5.810

10.  PCB118 Induces Inflammation of Islet Beta Cells via Activating ROS-NLRP3 Inflammasome Signaling.

Authors:  Chunxia Jiang; Yuping Wang; Man Guo; Yang Long; Jiao Chen; Fang Fan; Shi Tang; Yong Xu
Journal:  Biomed Res Int       Date:  2021-05-17       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.